-
Controversial Impact Factor Gets a Heavyweight Rival
Dec 8, 2016, 11:11 AM by Michael CroftNature News & Comment | On December 8, Elsevier launched the CiteScore Index, a new way to assess the quality of academic journals. Elsevier's CiteScore uses a larger database - and provides different results than the Journal Impact Factor.Full story -
Infectious Disease Testing Dominates the Ancillary Hospital Location Diagnostic Testing due to High Prevalence Rate of the Infectious Diseases
Dec 8, 2016, 06:49 AM by Michael CroftALBANY,, NY, UNITED STATES - Dec 8, 2016 - Ancillary hospital location includes those support locations other than board, room, medical and nursing services that are offered to the patients during their course of careFull story -
Radioactive Diagnostic Agent Market is Witnessing Stiff Competition among Existing Radioactive Diagnostics Agent Manufacturers
Dec 8, 2016, 02:35 AM by Michael CroftALBANY,, NY, UNITED STATES - Dec 8, 2016 - Radioactive agents are the nucleus of an unstable atom which emits radiations such as alpha, beta, gamma and X-rays and loses its energyFull story -
United States Positive End Expiratory Pressure (PEEP) Valve Industry Opportunity
Dec 8, 2016, 01:54 AM by Michael CroftSAN FRANCISCO, CA, UNITED STATES - Dec 8, 2016 - United States Positive End Expiratory Pressure (PEEP) Valve Industry 2016 Market Research Report analysed the current state in the definitions, classifications, applications and industry chain structureFull story -
Big Data Holds Key to Life Saving Discoveries Says Biomatters Whitepaper
Dec 7, 2016, 17:48 PM by Michael CroftAUCKLAND, NEW ZEALAND - Dec 8, 2016 - A whitepaper released today by bioinformatics technology company Biomatters examines the critical role big data will play in enabling scientists to discover life saving biologic drugs of the futureFull story -
Biotech Trial of the Century Could Determine Who Owns CRISPR
Dec 7, 2016, 13:33 PM by Michael CroftMIT Technology Review | Attorneys in a dispute over CRISPR gene-editing make their case to patent judges.Full story -
Biotech Has A Solution For The Clean Water Crisis
Dec 7, 2016, 10:42 AM by Michael CroftForbes | As peak oil fears fade, water has emerged as the next resource crisis. The solution comes from drug development biotechnologies honed by the pharmaceutical industry.Full story -
CRISPR Hearing Puts University of California on the Defensive
Dec 7, 2016, 10:27 AM by Michael CroftSTAT | The University of California has a steep hill to climb if it wants to overturn the 2014 decision awarding key CRISPR patents to the Broad Institute.Full story -
Elucigene partners with Congenica on new NGS cystic fibrosis kit
Dec 7, 2016, 05:22 AM by Michael CroftCAMBRIDGE, UK - Dec 7, 2016 - The emergence of new therapies that treat the causes of cystic fibrosis is creating an imperative for more accurate variant analysisFull story -
Linguamatics Introduces I2E AMP to Facilitate Rapid Clinical Decision Support
Dec 6, 2016, 12:17 PM by Michael CroftCAMBRIDGE, UK - Dec 6, 2016 - Text analytics provider Linguamatics today introduced the I2E Asynchronous Messaging Pipeline (AMP) platform to help healthcare professionals find critical clinical insights faster using Natural Language Processing (NLP)Full story -
AWS Wants To Dominate Beyond The Public Cloud With Lambda Updates
Dec 6, 2016, 10:56 AM by Michael CroftComputerworld | Two years ago, Amazon Web Services made a splash when it introduced Lambda. Now, the company has gone even further to bring that technology outside of its core data center regions.Full story -
At Late-Night ASH Talk Juno Execs Look Beyond Stalled Rocket Trial
Dec 6, 2016, 10:51 AM by Michael CroftXconomy | Juno Therapeutics is still mulling next steps for its lead product, an experimental cancer immunotherapy now stuck in limbo because five of 68 adult leukemia patients in its current study have died from severe brain swelling caused by the treatment.Full story -
Certara’s Simcyp Division Launches Quantitative Systems Toxicology Initiative
Dec 6, 2016, 08:12 AM by Michael CroftPRINCETON, NJ - Dec 6, 2016 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that it is extending its activities relating to drug safety assessment by establishing a new strategic Quantitative Systems Toxicology (QST) initiativeFull story -
Aridhia cements success with new office in Scotland’s precision medicine hub
Dec 6, 2016, 06:54 AM by Michael CroftEDINBURGH, UNITED KINGDOM - Dec 6, 2016 - Today clinical and translational informatics company, Aridhia, celebrate the opening of its new office in the Queen Elizabeth University Hospital, the largest acute hospital in Western EuropeFull story -
OPTRONICS Introduces TOMAHAWK a New Line of Economical Portable Videoscope System Packages for a Wide Range of Routine Industrial Remote Visual Inspection Applications.
Dec 5, 2016, 14:56 PM by Michael CroftGOLETA, CA - Dec 5, 2016 - ~~FOR IMMEDIATE RELEASEOPTRONICS Introduces TOMAHAWK a New Line of Economical Portable Videoscope System Packages for a Wide Range of Routine Industrial Remote Visual Inspection ApplicationsFull story -
SCRS and Greenphire Partner to Study Site Payment Processes Around the World
Dec 5, 2016, 14:45 PM by Michael CroftELLICOTT CITY, MD, UNITED STATES - Dec 2, 2016 - The Society for Clinical Research Sites (SCRS) and Greenphire have launched a research initiative to identify opportunities for optimization in global payment processesFull story -
Saneca to drive R&D Initiative following €1.5 million funding
Dec 5, 2016, 11:59 AM by Michael CroftHLOHOVEC, SLOVAKIA - Dec 5, 2016 - Contract development and manufacturing organisation (CDMO) Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a €1Full story -
Groundbreaking Big Data Platform Can Improve The Quality Of Cancer Care
Dec 5, 2016, 08:50 AM by Michael CroftFull storyBio-IT World Contributed Commentary | CancerLinQ helps to gain insights from the 97% of cancer patients not involved in clinical trials to help deliver better, more data-driven decision-making.
-
Eurofins Genomics Creates Streamlined DNA Synthesizer
Dec 2, 2016, 16:47 PM by Michael CroftLouisville Business First | Eurofins Genomics recently moved its headquarters to Louisville. Here's what they've been up to since.Full story -
TGen Joins City of Hope System
Dec 2, 2016, 13:20 PM by Michael CroftBio-IT World News Brief Translational Genomics Research Institute—TGen—has formed an alliance with City of Hope, a world-renowned independent research and cancer and diabetes treatment center, to make precision medicine a reality for patients. City of Hope hopes to provide a significant clinical setting to advance scientific discoveries made by TGen.Full story